Suppression of experimental autoimmune uveoretinitis with a combination of cyclosporin and alloprinol

Journal of Japanese Ophthalmological Society

Volumn 103, Issue 1, 1999, Pages 26-33

  Matuura, Gakushi ^a   Goto, Hiroshi ^a   Kezuka, Takeshi ^a   Yamakawa, Naoyuki ^a   Usui, Masahiko ^a  

^a TOKYO MEDICAL UNIVERSITY   (Japan)

Author keywords

Alloprinol; Cell mediated immunity; Cyclosporin; Experimental autoimmune uveoretinitis; Free radical

Indexed keywords

ALLOPURINOL; CYCLOSPORIN; FREE RADICAL; IMMUNOSUPPRESSIVE AGENT; INTERPHOTORECEPTOR RETINOID BINDING PROTEIN; SCAVENGER; XANTHINE OXIDASE INHIBITOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOIMMUNE DISEASE; CONTROLLED STUDY; DISEASE SEVERITY; HISTOPATHOLOGY; IMMUNIZATION; INCIDENCE; INFLAMMATION; LYMPHOCYTE PROLIFERATION; NEUTROPHIL; NONHUMAN; RAT; UVEORETINITIS;

ALLOPURINOL; ANIMALS; AUTOIMMUNE DISEASES; CYCLOSPORINE; FREE RADICAL SCAVENGERS; IMMUNOSUPPRESSIVE AGENTS; MALE; RATS; RATS, INBRED LEW; RETINITIS; UVEITIS; XANTHINE OXIDASE;

EID: 0032927542     PISSN: 00290203     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Handshumacher RE, Harding MW, Rice J, Drugge RJ: Cyclophirin A specific cytosolic binding protein for cyclosporin A. Sience 226 : 544-547, 1984.
2. Gunter KC, Irving SG, Zipfel PF, Siebenlist U, Kelly K : Cyclosporin A - mediated inhibition of mitogen - induced gene transcription is specific for the mitogenic stimulus and cell type. J Immunol 142 : 3286-3291, 1989.
3. Nussenblatt RB, Palestine AG, Chan C, Mochizuki M, Yancey K : Effectiveness of cyclosporin therapy for Behçet's disease. Arthritis Rheum 28 : 671-679, 1985.
4. Masuda K, Nakajima A, Urayama A, Nakae K, Kogure M, Inaba G : Double-masked trial of cyclosporin versus colchicine and long-term open study of cyclosporin in Behcet's disease. Lancet 20 May : 1093-1096, 1989.
5. Niwa Y, Miyake S, Sakane T, Shingu M, Yokoyama M. Auto oxidative damage in Behçet's disease-endothelial cell damage following the elevated oxygen radicals generated by stimulated neutrophils. Clin Exp Immunol 49 : 217-255, 1982.
6. Chocair P, Duley J, Simmonds HA, Cameron JS, Lanhez L, Arap S, et al : Low - dose allopurinol plus azathioprine cyclosporin/prednisolone, a novel immunosuppressive regimen. Lancet 342 : 83-84, 1993.
7. Redmond TM, Wiggert B, Robey FA, Nguyen NY, Lewis MS, Lee L, et al : Isolation and characterization of monkey interphotoreceptor retinoid -binding protein, a unique extracellular martrix component of the retina. Biochemistry 24 : 787-793, 1985.
8. Hirsh JG, Church AB : Studies of phagocytosis of group A streptococci by polymorphonuclear leukocytes in vitro. J Exp Med 111 : 309-322, 1960.
9. Spector T : Oxypurinol as an inhibitor of xanthine oxidase-catalyzed production of superoxide radical. Biochem Pharmacol 37 : 349-352, 1988.
10. Moorhouse CP, Grootveld M, Halliwell B, Quinlan GJ, Gutteridge CMJ : Allopurinol and oxypurinol are hydroxyl radical scavengers. FEBS Letters 213 : 23-28, 1987.
11. Scott LS, Mitchell HG : Cyclosporine toxicity associated with allopurinol. Southern Med J 85 : 1265-1266, 1992.
12. Wu GS, Goto H, Sevanian A, Rao NA : Generation of chemiluminescence in experimental autoimmune uveitis. Curr Eye Res 10 : 909-917, 1991.
13. Inselmann G, Hannemann J, Baumann K : Cyclosporine A induced lipid peroxidation and influence on glucose 6 phosphatase in rat hepatic and renal microsomes. Res Commun Chem Pathol Pharmacol 68 : 189-203, 1990.
14. Signe AB, Gerhard I, Rainer E, Hugo TH : Influences of Ginkgo biloba on cyclosporin A induced lipid peroxidation to vitamine E, glutathione and N-acetylcysteine. Biochem Pharmacol 41 : 1521-1526, 1991.
15. Hirose M, Kuroda Y : Reinforcement of cyclosporin A induced red cell destruction by superoxide. Tokushima J Exp Med 41 : 65-70, 1994.
16. Sakana T, Kotani H, Takada S, Tsunematsu T : Functional aberration of T cell from patients with Behçet's disease. Arthitis Rheum 25 : 1343-1351, 1982.